Additionally, a recent multicenter randomized controlled trial in China including 130 patients also showed that 10.8% of patients in ADG group had increased ALT levels, and 13.8% had hyperbilirubinemia, compared to 10.8% and 7.7% in the control group, respectively10. The gene discussed is GPT; the disease is isolated congenital adermatoglyphia.